Weekly Paclitaxel and Carboplatin against Advanced Transitional Cell Cancer after Failure of a Platinum-Based Regimen
- 31 October 2007
- journal article
- Published by Elsevier BV in European Urology
- Vol. 52 (4), 1115-1122
- https://doi.org/10.1016/j.eururo.2007.03.078
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Phase II Study of Pemetrexed for Second-Line Treatment of Transitional Cell Cancer of the UrotheliumJournal of Clinical Oncology, 2006
- A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimenBritish Journal of Cancer, 2006
- Phase II trial of carboplatin and paclitaxel in cisplatin‐pretreated advanced transitional cell carcinomaCancer, 2005
- Phase II Trial of Weekly Paclitaxel and Carboplatin Chemotherapy in Patients with Advanced Transitional Cell CancerEuropean Urology, 2005
- Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder CancerJournal of Clinical Oncology, 2005
- Phase II Multicenter Trial of a Weekly Paclitaxel and Carboplatin Regimen in Patients With Advanced Breast CancerJournal of Clinical Oncology, 2002
- A phase II study of gemcitabine in patients with transitional cell carcinoma of the urinary tract previously treated with platinumEuropean Journal Of Cancer, 1998
- Paclitaxel-based second-line therapy for patients with advanced chemotherapy-resistant bladder carcinoma (M1)Cancer, 1997
- Paclitaxel, Cisplatin and Methotrexate Combination Chemotherapy is Active in the Treatment of Refractory Urothelial MalignanciesJournal of Urology, 1995
- Phase II Trial of Ifosfamide, Fluorouracil, and Folinic Acid (FIFO Regimen) in Relapsed and Refractory Urothelial CancerCancer Investigation, 1995